111

ENSOL BIOSCIENCES

No trades
See on Supercharts

140610 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Ensol Biosciences, Inc. manufactures and sells drugs. The firm develops BT·IT convergence technology (the core bioinformatics technology) such as in-silico genome analysis system, transcriptome analysis system, proteome analysis system and metabolome analysis system. It has been investing in developing bio-hydrogen energy, bio-environments, bio-foods and bio-cosmetics. The company was founded by Hae-Jin Kim on February 20, 2001 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

140610 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company